• Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Managing Patients With Psoriasis and Psoriatic Arthritis: A Case-Based Clinical Conversation

Managing Patients With Psoriasis and Psoriatic Arthritis: A Case-Based Clinical Conversation

Format

Expert Perspective

Time to Complete

1 hour

Released

May 21, 2013

Expires

May 21, 2014

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurses

This educational initiative is provided by

Accredited Provider

Commercial Supporter

Support for this activity has been provided through educational grants from AbbVie and Amgen.

This activity has been created in collaboration with the NPF and the IPC.

Program Description

This activity presents a series of discussions on the clinical management of psoriasis and psoriatic arthritis from our expert faculty. Video vignettes depicting patient-clinician interactions in four separate case presentations are used to illustrate evidence-based best practices for diagnosing and treating patients with psoriasis and psoriatic arthritis. Disease management in the context of comorbid conditions is also discussed. The cases include a man with genital psoriasis and psoriatic arthritis; a woman of child-bearing age with severe scalp psoriasis; a woman with plaque psoriasis on the elbows, knees, and scalp who previously had cervical cancer; and a man with coronary artery disease who has palmoplantar psoriasis.

Intended Audience

This activity has been designed to meet the educational needs of dermatologists, dermatology nurses, nurse practitioners, physician assistants, and other health care professionals involved in the care of patients with moderate to severe psoriasis or psoriatic arthritis.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Outline appropriate, individualized treatment strategies in accordance with evidence-based recommendations
  • Integrate into practice strategies for managing safety-related issues in patients receiving therapy with traditional and biologic systemic agents
  • Implement strategies for managing a diverse set of patients with psoriasis that include consideration of comorbid disease and concomitant conditions
  • Question patients with psoriasis about joint involvement using the recommendations from the National Psoriasis Foundation Medical Board at every patient examination

Disclosure

In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:

Nurse Planner
Michelle Bernard, DNP, APRN, BC,
has disclosed no relevant financial relationships.

Curatio CME Institute
Daniel Duch, PhD,
Medical Director, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.
Francis M. Siri, Medical Writer, has disclosed no relevant financial relationships.

The University of Chicago Center for Continuing Medical Education
Marquetta A. Lewis, MS, CCMEP,
Director, has disclosed no relevant financial relationships.

The employees the National Psoriasis Foundation (NPF), the Society of Dermatology Physician Assistants (SDPA), the International Psoriasis Council (IPC), and the management and contractors of the DNA have disclosed no relevant financial relationships.

Faculty

Alan Menter, MD, Activity Chair
Chief of Dermatology
Baylor University Medical Center
Director, Baylor Psoriasis Research Center
Clinical Professor, University of Texas Southwestern Medical Center
Dallas, Texas

Alan Menter, MD, has disclosed the following relevant financial relationships:
Advisory Board/Speaker: Abbott, Amgen, Centocor, Galderma, Wyeth
Consultant: Abbott, Amgen, Centocor, Lilly, Galderma, Stiefel, Wyeth
Investigator: Abbott, Allergan, Amgen, Celgene, Centocor, Lilly, Novartis, Novo Nordisk, Pfizer, Stiefel, Syntrix Biosystems, Wyeth

Jerry Bagel, MD
Director
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey

Jerry Bagel, MD, has disclosed the following relevant financial relationships:
Consultant: Abbott, Amgen
Owner: Psoriasis Treatment Center of Central New Jersey
Research: Abbott, Amgen, Celgene, Galderma, Janssen, LEO Pharma, Lilly
Speaker: Abbott, Amgen, Galderma, Janssen, LEO Pharma

Jeffrey J. Crowley, MD
Bakersfield Dermatology & Skin Cancer Medical Group
Bakersfield, California
Assistant Clinical Professor
Department of Medicine
University of California
Los Angeles, California

Jeffrey J. Crowley, MD, has disclosed the following relevant financial relationships:
Consultant/Speaker: Abbott, Amgen
Research: Abbott, Amgen, Celgene, Lilly, Janssen, Merck, Pfizer
Speaker: Abbott, Amgen, Galderma, Janssen, LEO Pharma

Medium

The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Academy of Physician Assistants and the American Academy of Nurse Practitioners accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

The Dermatology Nurses’ Association (DNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

Designation Statement

Provider approved by the California Board of Registered Nursing (CBRN), Provider Number CEP5708.

Unapproved Product Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, the University of Chicago, the NPF, the SDPA, the IPC, the DNA, AbbVie, and Amgen do not recommend the use of any agent outside the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, the University of Chicago, the NPF, the SDPA, the IPC, the DNA, AbbVie, or Amgen. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a clinician regarding diagnosis and treatment of a specific patient’s medical condition.

The patients featured in the case scenarios are portrayed by actors.

Accreditation refers to educational content only and does not imply ANCC, CBRN, or DNA endorsement of any product or service.

Instructions

Method of Participation
There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 70% or better on the post-test. The post-test can be accessed at the end of the activity.

If you have any questions relating to the accreditation of this activity, please contact The University of Chicago Center for Continuing Medical Education by e-mail at cme@bsd.uchicago.edu or by phone at (773) 702-1056.

If you have any other questions relating to this activity, please contact myCME.Support@haymarketmedical.com.

Policy on Privacy and Confidentiality

Curatio CME Institute collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest. The information is not shared or used for commercial purposes unless prior permission has been granted by the user.

Curatio CME Institute may collect standard Web traffic data such as time and date of visit. Curatio CME Institute uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio CME Institute does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio CME Institute does, when required, provide the minimum subset of information to third parties that are responsible for accreditation of and issuance of certification for CME/CE tests. By participating in the Web-based activity, the user agrees that Curatio CME Institute has full permission to provide this minimum subset of information to the third parties as required by law.

myCME privacy policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Add to Queue